Physician profile
Batsirai Mutize
NPI 1750528733
$3,966.64
in general payments reported to CMS, 2019-2025
12 companies · $1,098 in 2025
The $1,098 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.56 · 2022: $107 · 2023: $1,399 · 2024: $1,350 · 2025: $1,098.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,847.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,510.03 | 2023-2025 | Mako, Triathlon, Insignia |
| Depuy Synthes Sales INC. | $129.20 | 2025 | Na |
| Ethicon US, LLC | $116.24 | 2023-2024 | Vicryl, Stratafix, Ethicon |
| Conetic Solutions, INC. | $69.01 | 2022 | |
| Integra Lifesciences Corporation | $37.34 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $17.35 | 2025 | Pico |
| Insulet Corporation | $16.59 | 2024 | Omnipod |
| Solventum Corporation | $16.54 | 2025 | Prevena, Activ.A.C., V.A.C.Instill |
| Heraeus Medical, LLC. | $15.25 | 2022 | |
| Convatec INC. | $13.33 | 2023 | |
| Recordati_rare_diseases_inc. | $13.20 | 2023 | Signifor Lar, Isturisa |
| Bioventus LLC | $12.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Batsirai Mutize listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.